Healthcare
Oncimmune
Oncimmune has developed a powerful new approach to the early diagnosis of primary cancer, cancer recurrence and the clinical management of cancer.
Blueskeye AI
BlueSkeye AI’s mission is to improve wellbeing and patient outcomes by building objective, accessible, scalable, affordable mobile device apps for mental health monitoring and putting them in the hands of the public as well as medical professionals.
Cerca Magnetics Limited
Cerca offer the world’s most advanced functional brain scanner – an integrated lightweight, ergonomic and wearable device that will offer an unparalleled window on human brain function, in health and disease.
Neurotherapeutics Ltd
Neurotherapeutics Solutions Ltd is a medical device company targeting neurological disorders with an initial focus on products to empower individuals with Tourette Syndrome to control their condition without surgical or pharmaceutical interventions.
The ReMEDI Project Ltd
A Reverse Mentoring framework for inclusion across all protected characteristics and with the socio-economically deprived groups, with the potential to bring organisational change.
FaHRAS Ltd
FaHRAS supplies a range of sophisticated evidence-based software systems that enable a user to run a variety of analyses against their family history to quantify their risk of developing breast, Lung and colorectal cancer.
Apollomics Inc.
Science-driven approach powering a pipeline of next-generation, combination and pan-cancer therapies for patients globally
IsomAb
IsomAb is a pre-clinical stage company with Proof-of-Concept data, in two animal models, and an ambitious plan to take its first product into the clinic by 2026.
TherageniX
TherageniX uses proprietary technology to deliver genes which can instruct the body to produce relevant proteins or factors that help in tissue regeneration.
Alevin Therapeutics
Groundbreaking new therapies for diseases with unmet clinical need
PeptiMatrix
PeptiMatrix™ is a fully synthetic and customisable peptide hydrogel platform designed for 3D cell culture, offering researchers a better solution for modelling development and disease in a more human-relevant way.
Locate Bio
Locate is based in MediCity and has developed a family of unique, thermally-activated, injectable scaffolds that solidify within the body and can be used to support tissue growth before degrading away.
Quantified Imaging
Quantified Imaging is developing new diagnostic technologies for neurodegeneration based on non-invasive MRI. These will improve early detection of disease and reduce scan costs
SurePulse Medical Ltd
SurePulse Medical is developing highly accurate heart rate measuring technology designed specifically for babies who need stabilisation or resuscitation at birth.
Exonate Ltd
Exonate develops and licenses Vascular Endothelial Growth Factors (VEGF) control agents that may be used as therapeutics in areas such as pain control, macular degeneration and cancer.
NuVision Biotherapies
NuVision has developed a unique way to process and preserve amnion which can be applied to the surface of the eye to promote healing of ‘front of eye’ disease and trauma.
